Trial Embedded in an Electronic Personal Medical Health Records

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT00972348
Collaborator
(none)
338
1
2
31
10.9

Study Details

Study Description

Brief Summary

This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that contains personal health information like medications, diagnosed conditions, allergies and laboratory values (like CD4 cells and viral load). This study will also help explain if a personal health record influences the relationship with a doctor or nurse practitioner and their patients. The purpose of this study is to determine if a personal health record will influence health. The content of your personal health record is as secure as possible for any online health information.

Condition or Disease Intervention/Treatment Phase
  • Other: Online access to a personal health record
  • Other: No access to the PHR
N/A

Detailed Description

HIV/AIDS is a non-curable chronic illness. Applying the chronic care model (CCM) to this disease may lead to improved outpatient based health care and easier clinical transitions for HIV infected patients. Clinical information systems (CIS) are a key element in the CCM and have three important roles: reminder systems; feedback mechanisms; and registries. CIS have focused on the provider as the recipient of critical data, however clinical information systems that target patients as consumers of information might also contribute to improved health care, especially for ambulatory patients. Personal health records (PHRs) are tools that would fit as a clinical information system for patients. PHRs allow patients (and others) to view data that are necessary to guide practical outpatient decisions. PHRs can become platforms to support the CIS elements too, allowing patients to receive and understand information, engage in their healthcare and influence their health outcomes. Our central hypothesis is that a secure enhanced PHR (ePHR) that combines meaningful information, web-based tools for support and reminders for patients will also provide a substantial opportunity to promote self-management and will lead to improved health outcomes. In this proposal we will work directly with HIV/AIDS patients in a public health setting to model processes that contribute to improved health outcomes in the realms of patient behaviors, patient-clinician trust, clinical outcomes, medication safety and utilization. Accordingly, the specific aims are:

  1. (Build Infrastructure and Content) Extend and secure a web-based PHR for HIV/AIDS patients receiving care in a public health setting providing these users with tools to access and understand their medical record including resources for decision support, information retrieval and communication. Specific content will include access to support for tobacco cessation, depression abatement, anxiety reduction, and medication adherence improvement.

  2. (Evaluation of PHR) Evaluation of patient and clinician experience with PHR including patient access and use patterns including use of support for tobacco cessation, depression abatement, anxiety reduction, adherence improvement., patient and clinician satisfaction with ePHR.

  3. (Outcome Assessment) Evaluation in 5 domains: quality of the patient-clinician interaction (trust, communication, health promotion); changes in patient behaviors (risk behaviors, adherence to antiretroviral medications, tobacco use); clinical outcomes (CD4+ T-lymphocytes, detectable plasma HIV RNA, depression, anxiety, quality of life); safety (documentation of drug allergies, adverse events, medication reconciliation); and utilization (office visits).

Study Design

Study Type:
Interventional
Actual Enrollment :
338 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Randomized Controlled Trial Embedded in an Electronic Medical Record (myHERO).
Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Feb 1, 2012
Actual Study Completion Date :
Feb 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Access to Personal Health Record

Full access to the Personal Health Record including lists of diagnoses, medications and laboratory values.

Other: Online access to a personal health record
Patients in the intervention arm have full access to their online personal health record

Active Comparator: No access to the PHR

No access to the PHR but patients will complete surveys.

Other: No access to the PHR
Patients will not be given access to their PHR but will complete online surveys.

Outcome Measures

Primary Outcome Measures

  1. The primary analyses of the trial data will compare the two study groups with respect to (1) 12-month change in CD4 T-cell count and (2) 12-month proportion of patients whose HIV viral load (VL) level is detectable. [12 months of participation]

Secondary Outcome Measures

  1. Alleviation of depression, among patients who are depressed at baseline. [12 months]

  2. Smoking cessation, among patients who are smokers at baseline. [12 months]

  3. Trust between physicians and patients. [12 months]

  4. Medication reconciliation. [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Evidence of HIV-1 infection, based on patient's medical history or laboratory tests.

  2. 18 years of age or older

  3. Receiving primary medical care at the Positive Health Program, SFGH.

  4. Able and willing to give informed consent.

  5. Willing to use the patient portal

Exclusion Criteria:
  1. Unwilling or unable to provide informed consent.

  2. No access to the web at any convenient location.

  3. Not willing to respond to online surveys or questionnaires.

  4. Already with access to the myHERO system

Contacts and Locations

Locations

Site City State Country Postal Code
1 HIV AIDS outpatient clinic at Ward 86 San Francisco California United States 94110

Sponsors and Collaborators

  • University of California, San Francisco

Investigators

  • Principal Investigator: James Kahn, MD, University of California
  • Study Director: David Thom, MD, PhD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00972348
Other Study ID Numbers:
  • H2598-33964
  • R18HS017784
First Posted:
Sep 4, 2009
Last Update Posted:
Nov 20, 2013
Last Verified:
Nov 1, 2013
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 20, 2013